Most U.S. adults with the strongest guideline recommendations for primary prevention with statins are not receiving them, including those with diabetes, extremely high cholesterol levels, or 10-year risk of cardiovascular disease over 20%, a study found.
5 Dec 2023
Women, older adults, and those with peripheral artery disease and cerebrovascular disease are particularly likely not to receive statins, according to an industry-funded analysis of lipid-lowering therapy use.
8 Aug 2023
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
1 Jan 2024
Statin therapy caused approximately 11 reports of any muscle pain or weakness per 1,000 treated patients during the first year of use, but little after, according to an analysis of placebo-controlled trials and trials of more intensive versus less intensive statin therapy.
6 Sep 2022
Removing race from the pooled cohort risk equations for cardiovascular disease (CVD) did not affect accuracy, according to results of a recent study, while another tested a prediction model based only on sex, age, and routine lab tests.
12 Dec 2023
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
1 Apr 2017
Patients older than age 75 years were less likely to receive moderate- or high-intensity statins than those ages 65 to 75 years despite their higher incidence of atherosclerotic cardiovascular disease.
21 Sep 2021
Guidelines for reducing cardiovascular risk are shifting with the evidence.
1 Jun 2017
Three months after 200 primary care patients in the U.K. who previously reported muscle symptoms from statins underwent a series of randomized, placebo-controlled, n-of-one trials, about two-thirds said they planned to restart statin treatment.
2 Mar 2021
Statins were associated with preserved cognitive ability in some subgroups, and the study may offer reassurance to patients concerned about statins' effects on the brain, study authors wrote.
19 Nov 2019